throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________
`
`EDWARDS LIFESCIENCES CORPORATION, EDWARDS
`LIFESCIENCES LLC, AND EDWARDS LIFESCIENCES AG,
`
`Petitioners,
`
`v.
`
`BOSTON SCIENTIFIC SCIMED, INC.,
`
`Patent Owner.
`_______________
`
`Case IPR2017-00060
`Patent 8,992,608
`_______________
`
`PATENT OWNER’S UPDATED EXHIBIT LIST
`
`Mail Stop PATENT BOARD
`Patent Trial and Appeal Board
`U.S. Patent & Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`

`

`PATENT OWNER’S UPDATED EXHIBIT LIST
`
`Description
`Sapien 3 Brochure, “Transcatheter Aortic Valve Replacement with
`the Edwards SAPIEN 3 Transcatheter Heart Valve,” 2016
`Press Release: FDA approves expanded indication for two
`transcatheter heart valves for patients at intermediate risk for death
`or complications associated with open-heart surgery, FDA
`8/18/2016
`Thourani, V. H., et al., Transcatheter aortic valve replacement
`versus surgical valve replacement in intermediate-risk patients : a
`propensity score analysis, The Lancet, Apr. 3, 2016
`Lerakis et al., Paravalvular Aortic Leak After Transcatheter Aortic
`Valve Replacement Current Knowledge, Circulation, Jan. 22, 2013,
`p. 397-407
`Cribier et al., Mid-Term Experience of Percutaneous Heart Valves,
`JACC 47:1214:23 (2006)
`Bentall, H.H., De Bono, A.: A technique for complete replacement
`of the ascending aorta, Thorax, 23:338-39 (1968)
`Order re: Motions for Summary Judgment, Medtronic Inc. v.
`Edwards Lifesciences Corp., et al., No. 12-0327, Dkt. 414 (C.D.
`Cal. Sept. 17, 2013)
`Report and Recommendation at 11, n.6, W.L. Gore & Assocs. v.
`C.R. Bard, Inc., Civ. A. No. 11-515-LPS-CJB, Dkt. 428 (D. Del.
`Nov. 9, 2015)
`Declaration of Marc A. Cohn in Support of Motion for Pro Hac
`Vice Admission (May 9, 2017)
`Declaration of Matthew M. Wolf in Support of Motion for Pro Hac
`Vice Admission (May 9, 2017)
`Declaration of Edward Han in Support of Motion for Pro Hac Vice
`Admission (May 9, 2017)
`Proposed Stipulated Protective Order (June 20, 2017)
`
`Comparison to Default Protective Order (June 20, 2017)
`
`Exhibit No.
`2001
`
`2002
`
`2003
`
`2004
`
`2005
`
`2006
`
`2007
`
`2008
`
`2009
`
`2010
`
`2011
`
`2012
`
`2013
`
`-1-
`
`

`

`Exhibit No.
`
`2014
`
`2015
`
`2016
`
`2017
`
`2018
`
`2019
`
`2020
`
`2021
`
`2022
`
`2023
`
`2024
`
`2025
`
`2026
`
`Description
`Edwards SAPIEN Transcatheter Heart Valve (THV) - P100041,
`U.S. Food & Drug Admin. (Sept. 6, 2013), https://wayback.archive-
`it.org/7993/20161023015438/http:/www.fda.gov/MedicalDevices/
`ProductsandMedicalProcedures/DeviceApprovalsandClearances/
`Recently-ApprovedDevices/ucm280840.htm
`Press Release: Edwards Lifesciences Receives CE Mark for
`Edwards SAPIEN Transcatheter Heart Valve, Edwards Lifesciences
`(Sept. 5, 2007)
`Press Release: Edwards Lifesciences Announces First Human
`Implants With 18 French Transcatheter Valve System, Edwards
`Lifesciences (May 14, 2009)
`SAPIEN XT Valve Product Overview, Edwards Lifesciences,
`http://www.edwards.com/devices/heart-valves/sapien-xt-valve (last
`visited June 21, 2017)
`Ramin S. Hastings & Isaac George, The Sapien 3 Valve, Cardiac
`Interventions Today, Mar./Apr. 2016
`Susheel Kodali et al., Paravalvular Regurgitation after
`Transcatheter Aortic Valve Replacement with the Edwards Sapien
`Valve in the PARTNER trial: characterizing patients and impact on
`outcomes, Eur. Heart J. (2014)
`Press Release: Edwards Lifesciences Receives FDA Approval for
`First Catheter-Based Aortic Heart Valve in the U.S., Edwards
`Lifesciences (Nov. 2, 2011)
`Press Release: Edwards Lifesciences Launching Sapien XT Valve
`In The U.S., Edwards Lifesciences (June 16, 2014)
`TAVR By Edwards: Our Latest Valve, Edwards Lifesciences,
`https://tavrbyedwards.com/our-latest-heart-valve-sapien-3 (last
`visited Nov. 14, 2016)
`Press Release: Edwards Receives European Approval for Advanced
`SAPIEN 3 Valve, Edwards Lifesciences (Jan. 27, 2014)
`Takahide Arai et al., Comparison of Edwards SAPIEN 3 versus
`SAPIEN XT in transfemoral transcatheter aortic valve implantation:
`Difference of valve selection in the real world, J. Cardiology (2016)
`Edwards Lifesciences (EW) Michael A. Mussallem on Q1 2015
`Results - Earnings Call Transcript
`Edwards Lifesciences (EW) Michael A. Mussallem on Q4 2015
`Results - Earnings Call Transcript
`
`-2-
`
`

`

`Exhibit No.
`
`2027
`
`2028
`
`2029
`
`2030
`
`2031
`
`2032
`
`2033
`
`2034
`
`2035
`
`2036
`
`2037
`
`2038
`
`2039
`
`2040
`
`2041
`
`Description
`Press Release: Edwards SAPIEN 3 Transcatheter Heart Valve
`Receives Expanded Indication From FDA, Edwards Lifesciences
`(Aug. 18, 2016)
`Deposition Transcript of Nigel P. Buller, M.D., dated June 15, 2017
`
`Transcript of Proceedings, Cordis Corp. v. Boston Scientific Corp.,
`No. 10-39-SLR, Dkt. 275 (D. Del. May 11, 2012)
`U.S. Patent No. 7,276,078 to Spenser et al.
`
`Slide Deck titled “SAPIEN 3 26mm CDR Nov 2010”
`(EDWARDS 01933840-939)
`Boston Scientific Corp. v. Edwards Lifesciences Corp., No. 16-275-
`SLR-SRF, Dkt. 186 (D. Del. June 1, 2017)
`Edwards SAPIEN 3 Transcatheter Heart Valve, Edwards
`Lifesciences, http://www.edwards.com/devices/Heart-Valves/
`Transcatheter-Sapien-3 (last visited June 21, 2017)
`Slide Deck titled “Edwards SAPIEN 3 Transcatheter Heart Valve
`with the Edwards Commander System 23/26/29 mm Sizes
`Procedural Training Manual” (EDWARDS 01026580-751)
`Photograph of Sapien 3 Valve (BSC-EDW0059565)
`
`Permanent PVL Locking Stitch to Skirt, Element ID 220
`(EDWARDS 01026527-35)
`Press Release: FDA approves SAPIEN 3 THV artificial heart valve,
`FDA (June 17, 2015)
`TAVItalk Designing the Future of TAVI - A Technology-Focused
`Edition: The SAPIEN 3 Valve, Edwards Lifesciences, Summer
`2014
`Document titled “Meeting with Physicians: PHV sizing and
`paravalvular Leak” dated May 23, 2003 (EDWARDS00743914-18)
`Patent application (EDWARDS 01032820-88)
`
`Document titled “Summary of Stanley’s and Larry’s visit July 27-
`29, 2004” (EDWARDS 01033971-90)
`
`-3-
`
`

`

`Exhibit No.
`
`2042
`
`2043
`
`2044
`
`2045
`
`2046
`
`2047
`
`2048
`
`2049
`
`2050
`
`2051
`
`2052
`
`Description
`Document titled “Visit Summary Stu, Keith, Jan, Mark K., Larry,
`Stanley & Laksen,” dated May 24, 2006 (EDWARDS 01033782-
`825)
`Document titled “Summary of Management Quarterly Visit July
`12-14, 2005” (EDWARDS 01033844-86)
`Slide Deck titled “THV2 Design Commitment Review,” dated May
`13, 2007 (EDWARDS00260617-58)
`Slide Deck titled “PHV2,” dated March 2006 (EDWARDS
`02438701-26)
`Slide Deck titled “Limited Clinical Feasibility (FIM) Design
`Review SAPIEN 3 with the NovaFlex 4 Delivery System (DS) and
`Accessories” (EDWARDS 0174788-849)
`Document titled “FACT SHEET: Cribier-Edwards Percutaneous
`Aortic Heart Valve,” Edwards Lifesciences
`Ali N. Azadani et al., Energy Loss Due to Paravalvular Leak With
`Transcatheter Aortic Valve Implantation, 88 Annals Thoracic
`Surgery 1857 (2009)
`Philippe Généreux et al., Paravalvular Leak After Transcatheter
`Aortic Valve Replacement, 61 J. Am. C. Cardiology 1125 (2013)
`Ignacio Cruz-González et al., Paravalvular Leak Closure After
`Transcatheter Aortic Valve Implantation Simultaneously Using
`Amplatzer Vascular Plug III and IV Devices, 68 Revista Española
`Cardiologia 1035 (2015)
`Martin B. Leon slide deck titled “A Randomized Evaluation of the
`SAPIEN XT Transcatheter Valve System in Patients with Aortic
`Stenosis Who Are Not Candidates for Surgery: PARTNER II,
`Inoperable Cohort,” dated March 10, 2013, available at
`http://www.acc.org/~/media/Clinical/PDF-Files/Approved-
`PDFs/2011/04/04/07/06/PARTNER-2-ACC13-Presentation-
`Slides.pdf
`Vinod H. Thourani slide deck titled “SAPIEN 3 Transcatheter
`Aortic Valve Replacement Compared with Surgery in Intermediate-
`Risk Patients: A Propensity Score Analysis,” dated April 3, 2016,
`available at https://www.acc.org/~/media/Clinical/PDF-Files/
`Approved-PDFs/2016/03/29/08/33/SUN%201145am%20ACC16
`%20Slides%20PARTNER%20II%20Sapien%203.ppt
`
`-4-
`
`

`

`Exhibit No.
`
`2053
`
`2054
`
`2055
`
`2056
`
`2057
`
`2058
`
`2059
`
`2060
`
`2061
`
`Description
`Thomas Walther et al., Transapical Minimally Invasive Aortic
`Valve Implantation Multicenter Experience, 116 Circulation I-240
`(2017)
`Alec Vahanian et al., Transcatheter valve implantation for patients
`with aortic stenosis: a position statement from the European
`Association of Cardio-Thoracic Surgery (EACTS) and the
`European Society of Cardiology (ESC), in collaboration with the
`European Association of Percutaneous Cardiovascular Interventions
`(EAPCI), 34 Eur. J. Cardio-thoracic Surgery 1 (2008)
`Slide Deck titled “Edwards LifeSciences: Transcatheter Aortic
`Valve Implantation Product Attribute Study Report,” dated July
`2011 (EDWARDS 02186714-69)
`Slide Deck titled “THV Competitive Deep Dive,” dated November
`2008 (EDWARDS 02079411-527)
`Slide Deck titled “SAPIEN 3 - US Team Download,” dated Nov.
`21, 2014 (EDWARDS 01809151-282)
`Dave Fornell, Transcatheter Repair of Paravalvular Leak,
`Diagnostic & Interventional Cardiology, Feb. 8, 2016,
`http://www.dicardiology.com/article/transcatheter(cid:173)repair(cid:173)
`paravalvular(cid:173)leak
`Tae-Hyun Yang et al., Incidence and Severity of Paravalvular
`Aortic Regurgitation With Multidetector Computed Tomography
`Nominal Area Oversizing or Undersizing After Transcatheter Heart
`Valve Replacement With the Sapien 3, 8 JACC: Cardiovascular
`Interventions 462 (2015)
`Robert P. Gooley, Comparison of Self-Expanding and
`Mechanically Expanded Transcatheter Aortic Valve Prostheses, 8
`JACC: Cardiovascular Interventions 962 (2015)
`B. Gonska et al., Comparison of the new balloon-expandable
`Edwards Sapien 3 valve with the self-expanding Medtronic
`corevalve for transfemoral aortic valve implantation in 200 patients,
`EuroIntervention, May 15, 2015, https://www.pcronline.com/
`eurointervention/AbstractsEuroPCR2015/abstracts-europcr-
`2015/POS291/comparison-of-the-new-balloon-expandable-
`edwards-sapien-3-valve-with-the-self-expanding-medtronic-
`corevalve-for-transfemoral-aortic-valve-implantation-in-200-
`patients.html
`
`-5-
`
`

`

`Exhibit No.
`
`2062
`
`2063
`
`2064
`
`2065
`
`2066
`
`2067
`
`2068
`
`2069
`
`2070
`
`2071
`
`2072
`
`2073
`
`2074
`
`2075
`
`Description
`Freek Nijhoff et al., Transcatheter Aortic Valve Implantation With
`the New Balloon-Expandable Sapien 3 Versus Sapien XT Valve
`System, Circulation: Cardiovascular Interventions, June 1, 2015,
`http://circinterventions.ahajournals.org/content/circcvint/8/6/
`e002408.full.pdf
`Document titled “Journey to S3,” dated May 8, 2016 (EDWARDS
`02399064-68)
`Press Release: Edwards Lifesciences Reports Fourth Quarter
`Results, Edwards Lifesciences (Feb. 1, 2017)
`Press Release: Edwards Receives FDA Approval for SAPIEN 3
`Transcatheter Heart Valve, Edwards Lifesciences (June 17, 2015)
`Press Release: Edwards Sapien 3 Transcatheter Heart Valve
`Receives Expanded Indication In Europe, Edwards Lifesciences
`(Sept. 19, 2016)
`Edwards Lifesciences’ (EW) CEO Michael Mussallem on Q4 2014
`Results - Earnings Call Transcript
`Edwards Lifesciences (EW) Michael A. Mussallem on Q2 2016
`Results - Earnings Call Transcript
`Aortic Valve, Wikipedia,
`https://en.wikipedia.org/wiki/Aortic_valve
`What is Severe Aortic Stenosis?, Medtronic,
`http://www.corevalve.com/us/what-severe-aortic-
`stenosis/index.htm
`Image No. 848 Gross pathology of rheumatic heart disease: aortic
`stenosis, CDC Public Health Image Library (PHIL),
`https://phil.cdc.gov/phil/details.asp?pid=848
`Matthew J. Czarny & Jon R. Resar, Diagnosis and Management of
`Valvular Aortic Stenosis, Clinical Medicine Insights: Cardiology
`2014:8(S1), 15-24
`Image of Hancock II Ultra valve, Medtronic,
`http://www.medtronic.com/content/dam/medtronic-com-m/mdt/
`cardsurg/images/hancock_ii_ultra_b.jpg
`Carpentier-Edwards PERIMOUNT Aortic Heart Valve, Edwards
`Lifesciences, http://www.edwards.com/eu/products/heartvalves/
`pages/perimountaortic.aspx
`Aortic Heart Valve with Conform-X Sewing Ring, CryoLife, Inc.,
`http://www.cryolife.com/products/on-x-heart-valves/
`
`-6-
`
`

`

`Exhibit No.
`
`2076
`
`2077
`
`2078
`
`2079
`
`2080
`
`2081
`
`2082
`
`2083
`
`2084
`
`2085
`
`2086
`
`2087
`
`2088
`
`2089
`
`2090
`
`Description
`Aorta scheme image, Wikimedia Commons,
`https://commons.wikimedia.org/wiki/File:Aorta_scheme.jpg
`Slide Deck titled “Designing the Future of TAVR” (EDWARDS
`01820001-48)
`Photograph of the Sapien 3 Valve (BSC-EDW0059563)
`
`Declaration of Dr. Andrew J. Manganaro in Support of Patent
`Owner’s Response (June 23, 2017)
`Declaration of Steven J. D. Brecker in Support of Patent Owner’s
`Response (June 23, 2017)
`Image of Heart Valve, WikiDoc,
`http://www.wikidoc.org/index.php/File:1687.jpg
`Sapien 3 Placement Video, Edwards Lifesciences, retrieved from
`http://www.edwards.com/devices/Heart-Valves/Transcatheter-
`Sapien-3
`Sapien 3 Transfemoral Animation, Edwards Lifesciences, retrieved
`from http://www.edwards.com/devices/Heart-Valves/Transcatheter-
`Sapien-3
`Sapien 3 Transformational Design Animations, Edwards
`Lifesciences, retrieved from
`http://www.edwards.com/devices/Heart-Valves/Transcatheter-
`Sapien-3
`Document titled “SAPIEN 3, PVL Skirt Meeting,” dated September
`16, 2011 (EDWARDS 01934680-84)
`Slide Deck titled “SAPIEN 3 Product Deep Dive” (EDWARDS
`01956628-77)
`Orange Gasket Video (EDWARDS01029569)
`
`Document titled “SAPIEN 3, PVL Skirt Meeting,” dated September
`16, 2011 (EDWARDS 01756438)
`Email chain dated March 20, 2013 (EDWARDS 02405909-10)
`
`Slide Deck titled “THV Sales Meeting,” dated Jan. 9, 2014
`(EDWARDS 01807655-707)
`
`-7-
`
`

`

`Exhibit No.
`
`2091
`
`2092
`
`2093
`
`2094
`
`2095
`
`2096
`
`2097
`
`2098
`
`2099
`
`Description
`Email chain dated Aug. 8, 2011 (EDWARDS 02186713)
`
`Proposed Stipulated Protective Order (July 28, 2017)
`
`Comparison to Default Protective Order (July 28, 2017)
`
`Deposition Transcript of Nigel P. Buller, M.D., dated October 17,
`2017
`Drawing, Exhibit A to Dr. Buller Deposition, October 17, 2017
`
`Deposition Transcript of Larry Wood, dated October 19, 2017
`
`Kodali et al., Two-Year Outcomes After Transcatheter or Surgical
`Aortic-Valve Replacement, N. Engl. J. Med., vol. 366 (2012)
`Deposition Transcript of Larry Wood, dated June 13, 2017
`
`Document titled “Global THV - Q2 2016 Update” dated July 12,
`2016 (EDWARDS 02146627-95)
`
`Dated: November 3, 2017
`
`Respectfully submitted,
`/s Jennifer A. Sklenar/
`Jennifer A. Sklenar (Reg. No. 40,205)
`Wallace Wu (Reg. No. 45,380)
`ARNOLD & PORTER KAYE
`SCHOLER LLP
`777 S. Figueroa Street, 44th Floor
`Los Angeles, CA 90017-5844
`Tel:
`(213) 243-4000
`Fax: (213) 243-4199
`
`Attorneys for Patent Owner Boston
`Scientific Scimed, Inc.
`
`-8-
`
`

`

`CERTIFICATE OF SERVICE
`
`The undersigned certifies that a copy of PATENT OWNER’S UPDATED
`EXHIBIT LIST and Exhibits 2094-2099 were served on November 3, 2017, to the
`following Counsel for Petitioner via e-mail:
`
`Gregory S. Cordrey (Reg. No. 44,089)
`Jeffer Mangels Butler & Mitchell, LLP
`3 Park Plaza, Suite 1100
`Irvine, CA 926214
`Email: gcordrey@jmbm.com
`Telephone: 949-623-7200
`Facsimile: 949-623-7201
`
`Brian Egan (Reg. No. 54,866)
`Morris, Nichols, Arsht & Tunnell, LLP
`1201 North Market Street
`P.O. Box 1347
`Wilmington, DE 19899-1347
`Email: began@MNAT.com
`Telephone: 302-351-9454
`Facsimile: 302-498-6216
`
`Catherine Nyarardy (Reg. No. 42,042)
`Paul, Weiss, Rifkind, Wharton &
`Garrison, LLP
`1285 Avenue of the Americas
`New York, NY 10019
`Email: cnyarardy@paulweiss.com
`Telephone: 212-373-3532
`Facsimile: 212-492-0532
`
`Attorneys for Petitioners Edwards Lifesciences Corporation, Edwards Lifesciences
`LLC, and Edwards Lifesciences AG
`
`/Jennifer A. Sklenar/
`Jennifer A. Sklenar (Reg. No. 40,205)
`ARNOLD & PORTER KAYE
`SCHOLER LLP
`777 S. Figueroa Street, 44th Floor
`Los Angeles, CA 90017-5844
`Tel:
`(213) 243-4000
`Fax: (213) 243-4199
`
`- i -
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket